Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04984590 · ClinicalTrials.gov registry record
Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects
A clinical trial of Age-related Macular Degeneration and Low Vision, sponsored by OnPoint Vision.
- Completed
- Registry status
- 9
- Enrollment target
- 1
- Study location
NCT04984590: Completed study of Age-related Macular Degeneration and Low Vision, sponsored by OnPoint Vision.
NCT04984590 is a study of Age-related Macular Degeneration and Low Vision that has completed, run by OnPoint Vision. The registered enrollment target is 9 participants, below the 1,508-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04984590, a study of Age-related Macular Degeneration and Low Vision, has completed, sponsored by OnPoint Vision.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiving the IOPCL (intraocular pseudophakic capsular lens). Subject will be followed for a period of 12-months.
Primary Outcome
Measuring postoperative tilt of the PCIOL and IOPCL MAG complex. Tilt was defined as less than or equal to 10 degrees.
Conditions Studied
Interventions
- DEVICE IOPCL AMD MAG
Study Locations (1)
California
- Harvard Eye Associates - Laguna Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2024-03-20 |
What the finished NCT04984590 record still lists
NCT04984590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,508-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which IOPCL AMD MAG is the first listed.
NCT04984590 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04984590 about?
NCT04984590 is a clinical study titled "Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects". This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiv...
What is the current status of trial NCT04984590?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2022-01-21. Estimated completion is 2024-03-20.
What conditions does trial NCT04984590 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Low Vision.
What interventions are being tested in trial NCT04984590?
The interventions under investigation include: IOPCL AMD MAG (DEVICE).
Who is sponsoring clinical trial NCT04984590?
This trial is sponsored by OnPoint Vision, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04984590 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04984590's enrollment target sits among peer trials
9 73rd of 74 the lowest of 74 other Age-related Macular Degeneration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Macular Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI